Table 3.
LFQ (max quant) list of up regulated proteins
| S. no. | Protein ID | Protein name | Peptides | Sequence coverage (%) | Mol. weight (kDa) | Fold change | ||
|---|---|---|---|---|---|---|---|---|
| 16 vs 0 days | 22 vs 0 days | 35 vs 0 days | ||||||
| 1 | gi|528953246 | Alpha-S1-casein isoform X2 | 2 | 12.4 | 20.1 | 1.5 | 1.9 | 1.6 |
| 2 | gi|741932316 | Complement C3 isoform X1 | 14 | 11.1 | 187.2 | 1.6 | 5.9 | 7.0 |
| 3 | gi|440895896 | Vitronectin | 8 | 15.5 | 53.6 | 1.7 | 1.9 | 2.8 |
| 4 | gi|741962549 | Pigment epithelium-derived factor | 2 | 14 | 24.2 | 1.6 | 4.6 | 5.0 |
| 5 | gi|28603766 | Plasma serine protease inhibitor precursor | 10 | 31.7 | 45.2 | 1.6 | 4.71 | 8.1 |
| 6 | gi|667665642 | Cathelicidin, partial | 9 | 57.4 | 17.6 | 1.7 | 7.1 | 5.1 |
| 7 | gi|68165959 | Insulin-like growth factor II, partial | 4 | 17.6 | 5.7 | 1.6 | 1.7 | 11.7 |
| 8 | gi|664764564 | Polymeric immunoglobulin receptor | 2 | 1.3 | 82.9 | 2.1 | 4.2 | 7.1 |
| 9 | gi|803268763 | Calbindin | 2 | 9.2 | 29.9 | 1.5 | 3.8 | 14.5 |
| 10 | gi|741969869 | Fibulin-2 isoform X1 | 3 | 3.9 | 124.0 | 1.8 | 12.7 | 16.8 |
| 11 | gi|741905201 | Endosialin isoform X1, partial | 8 | 14.9 | 70.8 | 4.7 | 4.9 | 5.5 |
| 12 | gi|803331888 | Plasma serine protease inhibitor | 6 | 19.3 | 45.4 | 1.6 | 8.9 | 12.6 |
| 13 | gi|426254387 | Uromodulin | 13 | 19.8 | 69.8 | 1.9 | 2.5 | 2.5 |
| 14 | gi|440891627 | Cathelicidin-3, partial | 2 | 16.3 | 15.2 | 4.7 | 3.9 | 5.8 |
| 15 | gi|440893899 | Hypothetical protein M91_15215, partial | 2 | 3.1 | 69.0 | 2.2 | 4.7 | 8.3 |
| 16 | gi|440901185 | Ig lambda-1 chain C regions, partial | 5 | 68.6 | 11.1 | 1.7 | 1.6 | 6.1 |
| 17 | gi|741954224 | Mannan-binding lectin serine protease 2 isoform X2 | 6 | 34.1 | 20.3 | 3.2 | 4.7 | 11.8 |
| 18 | gi|803247194 | Nectin-2 isoform X4 | 3 | 8.8 | 51.3 | 2.4 | 3.4 | 9.9 |
| 19 | gi|528952645 | Extracellular superoxide dismutase [Cu-Zn] isoform X1 | 4 | 22 | 26.1 | 2.1 | 4.9 | 10.6 |
| 20 | gi|528953415 | Vitamin D-binding protein isoform X1 | 6 | 18.1 | 53.3 | 2.8 | 5.9 | 4.1 |
| 21 | gi|440906200 | Hypothetical protein M91_02830, partial | 2 | 9.4 | 19.4 | 4.3 | 1.9 | 1.8 |
| 22 | gi|594059057 | Zinc-alpha-2-glycoprotein-like | 2 | 5.4 | 34.0 | 3.0 | 3.3 | 2.1 |
| 23 | gi|594116459 | Retinol-binding protein 4-like, partial | 2 | 13 | 18.5 | 1.5 | 2.7 | 9.5 |
| 24 | gi|741973898 | Zymogen granule protein 16 homolog B-like | 3 | 18.1 | 16.9 | 6.2 | 4.8 | 1.6 |
| 25 | gi|741976749 | Deleted in malignant brain tumors 1 protein isoform X49 | 6 | 13 | 166.5 | 7.4 | 4.3 | 4.9 |
| 26 | gi|6137530 | B chain B, The crystal structure of calcium-free equine plasma gelsolin | 2 | 3.8 | 80.5 | 1.6 | 6.3 | 15.8 |
| 27 | P02672 | Fibrinogen alpha chain precursor | 3 | 6.2 | 67.0 | 2.1 | 3.2 | 3.3 |
| 28 | gi|741959425 | Major allergen I polypeptide chain 2-like | 2 | 21.4 | 12.6 | 1.4 | 3.0 | 4.3 |